相关实验视频
Updated: Jul 24, 2026
09:00
A Multi-detection Assay for Malaria Transmitting Mosquitoes
Published on: February 28, 2015
13.2K
临床需求评估,为开发一种新的检测方法提供信息,以检测患者样本中的抗疟疾药物:一个案例研究
Erin S Coonahan1,2, Chanaki Amaratunga1, Carole A Long1
1Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
PLOS global public health
|August 24, 2023
概括
在东南亚开发一种新的基于aptamer的传感器用于抗疟疾药物,涉及到最终用户的合作. 这种方法确保了改善医疗保健获取的临床影响和运营可行性.
科学领域:
- 生物医学工程 生物医学工程
- 诊断 诊断 诊断 诊断
- 全球健康 全球健康
背景情况:
- 护理点测试提高了全球医疗保健的获取,特别是农村地区的热带疾病.
- 技术进步和增加的资金刺激了新型诊断工具的开发.
- 由于缺乏临床整合,运营挑战以及缺乏最终用户输入,许多新测试都失败了.
研究的目的:
- 描述一种低成本的基于aptamer的传感器的开发过程,用于检测抗疟疾药物.
- 为了说明最终用户的反如何纳入测试设计,以提高可行性和影响.
- 通过协作设计,提出一种开发有效医疗保健技术的模型.
主要方法:
- 一个案例研究方法被用来开发一种新型的体传感器用于抗疟疾药物检测.
- 通过调查和采访与疟疾控制专家,研究人员和医疗保健工作者建立了目标产品概况.
- 来自最终用户的设计反在开发过程中对测试格式的修改提供了信息.
主要成果:
- 合作设计过程导致开发了一种低成本的aptamer传感器,专门用于检测患者样本中的抗疟疾药物.
- 终端用户的意见对于完善试验设计至关重要,确保其与临床决策和操作现实保持一致.
- 开发的aptamer传感器平台展示了检测其他小分子和蛋白质点的适应性.
结论:
- 医疗诊断点的成功开发需要与最终用户密切合作,以确保临床效用和运营可行性.
- 描述的开发过程为创建有效的新诊断试验提供了有价值的模型.
- 这种方法可以显著改善获得基本医疗保健技术的机会,特别是在资源有限的环境中.
相关概念视频
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...